eslicarbazepine acetate has been researched along with Abdominal Epilepsy in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (10.87) | 29.6817 |
2010's | 34 (73.91) | 24.3611 |
2020's | 7 (15.22) | 2.80 |
Authors | Studies |
---|---|
Hirsch, M; Immisch, I; Knake, S; Schulze-Bonhage, A | 1 |
Auvin, S; Falcão, AC; Gama, H; Kirkham, F; Moreira, J; Rocha, JF; Soares-da-Silva, P | 1 |
Ley, M; Principe, A; Rocamora, R | 1 |
Chaves, J; Ikedo, F; Moreira, J; Rocamora, R; Soares-da-Silva, P; Trinka, E | 1 |
Aparicio, J; García-Peñas, JJ; Roldán-Aparicio, S; Smeyers-Durá, P | 1 |
Fernández-Anaya, S; Rico-Villademoros, F; Rojo, R; Sarasa, P; Serratosa, JM; Villanueva, V | 1 |
Chang, XC; Hong, WK; Wang, Y; Xu, HQ; Yuan, H; Zheng, RY | 1 |
Camacho, JL; Castillo, A; Garcés, M; Giner, P; Giráldez, BG; Gómez-Ibáñez, A; Guillamón, E; López-Gomáriz, E; López-González, FJ; Mauri, JA; Molins, A; Palau, J; Rodríguez-Uranga, J; Salas-Puig, J; Serratosa, JM; Toledo, M; Torres, N; Villanueva, V | 1 |
Abou-Khalil, B; Biton, V; Blum, D; Cheng, H; Elger, CE; Gama, H; Grinnell, T; Krauss, G; Moreira, J; Rocha, JF; Rogin, JB; Trinka, E | 1 |
Galiana, GL; Gauthier, AC; Mattson, RH | 1 |
Cagnetti, C; Foschi, N; Lattanzi, S; Lorusso, A; Provinciali, L; Silvestrini, M | 1 |
Arjona-Padillo, A; Bertol-Alegre, V; Estévez-María, JC; Fernández-Pérez, J; Galván-Espinosa, J; García-Martínez, A; López-González, FJ; Maestre-Moreno, JF; Mauri-Llerda, JA; Molto-Jorda, JM; Payán-Ortiz, M; Querol-Pascual, R; Ruiz-Giménez, J; Serrano-Castro, PJ; Toledo-Argany, M; Tortosa-Conesa, D | 1 |
Andersen, NB; Nielsen, MK; Petrenaite, V | 1 |
Paule, E; Rosenow, F; Schubert-Bast, S; Strzelczyk, A; Willems, LM; Zöllner, JP | 1 |
Ben-Menachem, E; Elger, C; Keller, B; Kowacs, PA; Löffler, K; Rocha, JF; Soares-da-Silva, P; Trinka, E | 1 |
Brigo, F; Cagnetti, C; Grillo, E; Lattanzi, S; Silvestrini, M; Verrotti, A; Zaccara, G | 1 |
Abraira, L; Ortega, G; Quintana, M; Salas-Puig, J; Sanabria, A; Santamarina, E; Toledo, M | 1 |
Cimadevilla, JM; Fernández-Pérez, J; Payán-Ortiz, M; Quiroga-Subirana, P; Serrano-Castro, PJ | 1 |
Keating, GM | 1 |
Chaves, J; Correia, FD; Freitas, J; Lopes, J; Lopes-Lima, J; Magalhães, R; Ramalheira, J | 1 |
Buchneva, IA; Ermolenko, NA | 1 |
Blum, D; Cheng, H; Grinnell, T; Harvey, J; Sperling, MR | 1 |
Banach, M; Borowicz, KK; Czuczwar, SJ | 1 |
Bhatia, P; Blum, D; Cheng, H; Grinnell, T; Jacobson, MP; Pazdera, L | 1 |
Brodie, MJ | 1 |
Anastassopoulos, KP; Blum, D; Bond, TC; Cramer, JA; Gilliam, FG; Moreira, J; Rocha, F; Ryvlin, P; Specchio, LM; Velez, FF; Wang, X | 1 |
Bagul, M; Holtkamp, M; Kockelmann, E; McMurray, R; Sousa, R | 1 |
Dhillon, S; Shirley, M | 1 |
Ben-Menachem, E; Zelano, J | 1 |
Bragazzi, NL; Brigo, F; Nardone, R; Trinka, E | 1 |
Bermejo, P; Bonet, M; Camacho, JL; Campos, D; Galiano, ML; Garcés, M; Giner, P; Gómez-Ibáñez, A; López-González, FJ; Martínez, P; Massot-Tarrús, A; Mauri, JA; Montoya, J; Ojeda, J; Poza, JJ; Rodriguez-Osorio, X; Rodríguez-Uranga, J; Ruiz-Giménez, J; Toledo, M; Vilella, L; Villanueva, V; Zurita, J | 1 |
Ben-Menachem, E; Holtkamp, M; Peltola, J; Shorvon, SD; Steinhoff, BJ; Trinka, E; Villanueva, V | 1 |
Breia, P; Carvalho, M; Chaves, J; Fernandes, H; Gala, A; Grebe, H; Mateus, P; Mestre, A; Pelejão, R; Pimentel, J; Sousa, R | 1 |
Anastassopoulos, KP; Blum, D; Bond, TC; Cramer, JA; Sousa, R; Velez, FF; Wang, X | 1 |
McCormack, PL; Robinson, DM | 1 |
Ferreira, J; Mestre, T | 1 |
Almeida, L; Elger, C; Halász, P; Maia, J; Soares-da-Silva, P | 1 |
Almeida, L; Gil-Nagel, A; Lopes-Lima, J; Maia, J; Soares-da-Silva, P | 1 |
Owen, RT | 1 |
Almeida, L; Ben-Menachem, E; Gabbai, AA; Hufnagel, A; Maia, J; Soares-da-Silva, P | 1 |
Almeida, L; Cramer, JA; Członkowska, A; Elger, C; Guekht, A; Halász, P; Hodoba, D; Maia, J; Soares-da-Silva, P | 1 |
Luef, G; Rauchenzauner, M | 1 |
Chang, XC; Wang, Y; Xu, HQ; Yuan, H; Zheng, RY | 1 |
Almeida, L; Ben-Menachem, E; Falcão, A; Gabbai, AA; Hufnagel, A; Soares-da-Silva, P | 1 |
Almeida, L; Ben-Menachem, E; da-Silva, PS; Elger, C; Falcão, A; Gabbai, AA; Gil-Nagel, A; Halász, P; Lopes-Lima, J; Nunes, T | 1 |
Almeida, L; Bialer, M; Cramer, JA; Elger, C; Maia, J; Soares-da-Silva, P | 1 |
19 review(s) available for eslicarbazepine acetate and Abdominal Epilepsy
Article | Year |
---|---|
[The role of eslicarbazepine acetate in the treatment of focal-onset epilepsy in pediatric age: practical issues].
Topics: Adolescent; Anticonvulsants; Child; Dibenzazepines; Epilepsies, Partial; Humans | 2020 |
Initial monotherapy with eslicarbazepine acetate for the management of adult patients with focal epilepsy in clinical practice: a meta-analysis of observational studies.
Topics: Adult; Anticonvulsants; Dibenzazepines; Epilepsies, Partial; Humans; Randomized Controlled Trials as Topic; Retrospective Studies; Treatment Outcome | 2023 |
Eslicarbazepine acetate add-on therapy for drug-resistant focal epilepsy.
Topics: Adolescent; Adult; Age Factors; Aged; Anticonvulsants; Bias; Child; Dibenzazepines; Drug Resistant Epilepsy; Drug Therapy, Combination; Epilepsies, Partial; Humans; Intention to Treat Analysis; Middle Aged; Randomized Controlled Trials as Topic; Withholding Treatment; Young Adult | 2021 |
Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials.
Topics: Adolescent; Adult; Anticonvulsants; Clinical Trials, Phase III as Topic; Dibenzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Internationality; Male; Randomized Controlled Trials as Topic; Treatment Outcome; Voltage-Gated Sodium Channel Blockers; Young Adult | 2017 |
Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures.
Topics: Animals; Anticonvulsants; Cytochrome P-450 CYP2C19; Dibenzazepines; Drug Interactions; Epilepsies, Partial; Humans; Voltage-Gated Sodium Channel Blockers | 2017 |
Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence.
Topics: Adolescent; Adult; Anticonvulsants; Child; Dibenzazepines; Drug Interactions; Drug Monitoring; Epilepsies, Partial; Epilepsy, Generalized; Humans; Sodium | 2018 |
Adjunctive Eslicarbazepine Acetate in Pediatric Patients with Focal Epilepsy: A Systematic Review and Meta-Analysis.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Dibenzazepines; Epilepsies, Partial; Humans; Pediatrics; Randomized Controlled Trials as Topic | 2018 |
Eslicarbazepine acetate: a review of its use as adjunctive therapy in refractory partial-onset seizures.
Topics: Administration, Oral; Adult; Anticonvulsants; Dibenzazepines; Epilepsies, Partial; Humans; Voltage-Gated Sodium Channel Blockers | 2014 |
[Exalief as a newer antiepileptic drug for adjunctive therapy of refractory partial-onset seizures].
Topics: Anticonvulsants; Clinical Trials, Phase III as Topic; Dibenzazepines; Epilepsies, Partial; Humans; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Voltage-Gated Sodium Channel Blockers | 2014 |
Pharmacokinetic/pharmacodynamic evaluation of eslicarbazepine for the treatment of epilepsy.
Topics: Adult; Age Factors; Animals; Anticonvulsants; Carbamazepine; Child; Dibenzazepines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsies, Partial; Humans; Oxcarbazepine | 2015 |
Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.
Topics: Acetamides; Adult; Aged; Animals; Anticonvulsants; Carbamates; Dibenzazepines; Drug Resistant Epilepsy; Epilepsies, Partial; Female; Humans; Lacosamide; Male; Middle Aged; Nitriles; Phenylenediamines; Pyridones | 2015 |
Eslicarbazepine Acetate Monotherapy: A Review in Partial-Onset Seizures.
Topics: Administration, Oral; Anticonvulsants; Dibenzazepines; Epilepsies, Partial; Humans; Seizures | 2016 |
Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
Topics: Acetamides; Anticonvulsants; Dibenzazepines; Drug Therapy, Combination; Epilepsies, Partial; Humans; Lacosamide; Nitriles; Pyridones; Pyrrolidinones; Randomized Controlled Trials as Topic | 2016 |
Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.
Topics: Anticonvulsants; Clinical Trials, Phase III as Topic; Dibenzazepines; Drug Substitution; Epilepsies, Partial; Humans; Randomized Controlled Trials as Topic; Seizures | 2017 |
Eslicarbazepine acetate.
Topics: Animals; Dibenzazepines; Dose-Response Relationship, Drug; Epilepsies, Partial; Humans; Sodium Channel Blockers | 2009 |
Eslicarbazepine acetate: a new option for the treatment of focal epilepsy.
Topics: Animals; Anticonvulsants; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dibenzazepines; Epilepsies, Partial; Humans; Treatment Outcome | 2009 |
Eslicarbazepine acetate: A novel agent for the adjunctive treatment of epilepsy.
Topics: Animals; Anticonvulsants; Clinical Trials as Topic; Dibenzazepines; Drug Interactions; Epilepsies, Partial; Humans; Sodium Channel Blockers | 2010 |
Eslicarbazepine acetate for partial-onset seizures.
Topics: Anticonvulsants; Dibenzazepines; Dose-Response Relationship, Drug; Drug Interactions; Epilepsies, Partial; Humans; Treatment Outcome | 2011 |
Eslicarbazepine acetate add-on for drug-resistant partial epilepsy.
Topics: Adult; Aged; Anticonvulsants; Dibenzazepines; Drug Resistance; Drug Therapy, Combination; Epilepsies, Partial; Humans; Middle Aged; Randomized Controlled Trials as Topic; Young Adult | 2011 |
17 trial(s) available for eslicarbazepine acetate and Abdominal Epilepsy
Article | Year |
---|---|
Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Dibenzazepines; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Male; Treatment Outcome | 2020 |
Long-term efficacy and safety of eslicarbazepine acetate monotherapy for adults with newly diagnosed focal epilepsy: An open-label extension study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticonvulsants; Dibenzazepines; Double-Blind Method; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Time Factors; Treatment Outcome; Young Adult | 2020 |
Efficacy and safety of eslicarbazepine acetate versus controlled-release carbamazepine monotherapy in newly diagnosed epilepsy: A phase III double-blind, randomized, parallel-group, multicenter study.
Topics: Adult; Alanine Transaminase; Anticonvulsants; Carbamazepine; Delayed-Action Preparations; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsies, Partial; Equivalence Trials as Topic; Fatigue; Female; gamma-Glutamyltransferase; Headache; Humans; Logistic Models; Male; Middle Aged; Nausea; Treatment Outcome; Voltage-Gated Sodium Channel Blockers; Young Adult | 2018 |
[Social cognition and cognitive functions in patients with epilepsy treated with eslicarbazepine acetate].
Topics: Adult; Anticonvulsants; Anxiety; Cognition; Depression; Dibenzazepines; Dose-Response Relationship, Drug; Emotional Intelligence; Epilepsies, Partial; Executive Function; Female; Humans; Male; Middle Aged; Neuropsychological Tests; Prospective Studies; Quality of Life; Theory of Mind; Verbal Learning | 2018 |
[Eslicarbazepine acetate in clinical practice. Efficacy and safety results].
Topics: Acetamides; Adolescent; Adult; Aged; Anticonvulsants; Cognition Disorders; Depression; Dibenzazepines; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; Lacosamide; Male; Middle Aged; Sodium Channel Blockers; Weight Gain; Young Adult | 2013 |
Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a randomized historical-control phase III study based in North America.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Double-Blind Method; Drug Substitution; Epilepsies, Partial; Female; Humans; Male; Middle Aged; North America; Treatment Outcome; Young Adult | 2015 |
Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Double-Blind Method; Epilepsies, Partial; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Seizures; Treatment Outcome; Young Adult | 2015 |
Severity and burden of partial-onset seizures in a phase III trial of eslicarbazepine acetate.
Topics: Adult; Aged; Anticonvulsants; Cost of Illness; Dibenzazepines; Double-Blind Method; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Male; Middle Aged; Seizures; Severity of Illness Index; Surveys and Questionnaires | 2015 |
Real-world data on eslicarbazepine acetate as add-on to antiepileptic monotherapy.
Topics: Adult; Anticonvulsants; Dibenzazepines; Drug Therapy, Combination; Epilepsies, Partial; Europe; Female; Humans; Male; Middle Aged; Prospective Studies; Quality of Life; Treatment Outcome; Young Adult | 2016 |
Impact of seizure frequency reduction on health-related quality of life among clinical trial subjects with refractory partial-onset seizures: A pooled analysis of phase III clinical trials of eslicarbazepine acetate.
Topics: Adult; Anticonvulsants; Dibenzazepines; Double-Blind Method; Epilepsies, Partial; Female; Humans; Male; Mental Health; Middle Aged; Quality of Life; Seizures; Treatment Outcome | 2017 |
Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anticonvulsants; Dibenzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Epilepsies, Partial; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Treatment Outcome; Young Adult | 2009 |
Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Aged; Anticonvulsants; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Epilepsies, Partial; Female; Headache; Humans; Male; Middle Aged; Nausea; Patient Selection; Placebos; Seizures; Treatment Outcome | 2009 |
Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy.
Topics: Adult; Anticonvulsants; Dibenzazepines; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Epilepsies, Partial; Female; Headache; Humans; Male; Middle Aged; Nausea; Seizures; Treatment Outcome | 2010 |
Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Epilepsies, Partial; Epilepsy; Female; Health Status; Humans; Intention to Treat Analysis; Longitudinal Studies; Male; Middle Aged; Quality of Life; Surveys and Questionnaires; Treatment Outcome | 2010 |
Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension study.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Dibenzazepines; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Epilepsy; Female; Humans; Male; Middle Aged; Time Factors; Treatment Outcome; Young Adult | 2013 |
Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: integrated analysis of pooled data from double-blind phase III clinical studies.
Topics: Adult; Anticonvulsants; Dibenzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Male | 2013 |
Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures.
Topics: Adolescent; Adult; Anticonvulsants; Dibenzazepines; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Placebos; Treatment Outcome | 2007 |
10 other study(ies) available for eslicarbazepine acetate and Abdominal Epilepsy
Article | Year |
---|---|
A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal-Onset Epilepsy.
Topics: Adult; Anticonvulsants; Bone Density; Bone Diseases, Metabolic; Dibenzazepines; Epilepsies, Partial; Epilepsy; Female; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2023 |
[Long-term effects of dibenzazepines on metabolic parameters: retrospective comparison of carbamazepine, oxcarbazepine and eslicarbazepine acetate in the real world].
Topics: Adult; Aged; Alanine Transaminase; Anticonvulsants; Aspartate Aminotransferases; Carbamazepine; Dibenzazepines; Epilepsies, Partial; Female; Follow-Up Studies; gamma-Glutamyltransferase; Healthy Lifestyle; Humans; Hyponatremia; Leukocyte Count; Lipids; Male; Metabolism; Middle Aged; Nerve Tissue Proteins; Oxcarbazepine; Retrospective Studies; Sodium; Voltage-Gated Sodium Channels | 2020 |
Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: Case series.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Dibenzazepines; Epilepsies, Partial; Female; Humans; Male; Retrospective Studies; Treatment Outcome | 2017 |
Eslicarbazepine acetate as adjunctive treatment in partial-onset epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Dibenzazepines; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Oxcarbazepine; Retrospective Studies; Seizures; Young Adult | 2018 |
Eslicarbazepine acetate and carotid intima-media thickness in epileptic patients.
Topics: Adolescent; Adult; Aged; Carotid Intima-Media Thickness; Dibenzazepines; Epilepsies, Partial; Female; Humans; Hypertension; Male; Middle Aged; Retrospective Studies; Statistics, Nonparametric; Ultrasonography; Voltage-Gated Sodium Channel Blockers; Young Adult | 2017 |
Clinical experience with eslicarbazepine acetate in adults with sub-analysis of elderly.
Topics: Adult; Age Factors; Aged; Anticonvulsants; Carbamazepine; Dibenzazepines; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Retrospective Studies; Voltage-Gated Sodium Channel Blockers; Young Adult | 2017 |
Two-year follow-up with eslicarbazepine acetate: a consecutive, retrospective, observational study.
Topics: Adult; Dibenzazepines; Epilepsies, Partial; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Time Factors; Voltage-Gated Sodium Channel Blockers; Young Adult | 2014 |
Eslicarbazepine acetate for the treatment of partial epilepsy.
Topics: Dibenzazepines; Disease Management; Epilepsies, Partial; Humans | 2016 |
EARLY-ESLI study: Long-term experience with eslicarbazepine acetate after first monotherapy failure.
Topics: Adult; Aged; Anticonvulsants; Dibenzazepines; Dizziness; Epilepsies, Partial; Female; Humans; Hyponatremia; Male; Middle Aged; Retrospective Studies; Vertigo | 2017 |
Eslicarbazepine acetate as adjunctive therapy in clinical practice: ESLADOBA study.
Topics: Adult; Anticonvulsants; Dibenzazepines; Drug Therapy, Combination; Epilepsies, Partial; Female; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome | 2017 |